Mice exhibited a higher perfusion ratio in ischemic hindlimbs in both AD-MSCs and apelin groups compared with that of PBS group (Fig. 2B), with a much more pronounced improvement from combined therapy of AD-MSCs and apelin. Here, APLN is linked to Alzheimer disease.